D-0833-2016 Class III Terminated
FDA drug recall D-0833-2016 was initiated by AbbVie Inc. on Mar 24, 2016 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications The recall status is terminated (terminated Oct 20, 2016). Affected quantity: 307 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 27, 2016
- Initiation Date
- Mar 24, 2016
- Termination Date
- Oct 20, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 307 bottles
Product description
Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.
Reason for recall
Failed Content Uniformity Specifications
Distribution pattern
Nationwide
Code information
Lot #1055586, Exp.1/21/ 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0833-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for AbbVie Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.